病理分级决定门诊KTP激光治疗声带白斑的临床疗效
该回顾性研究纳入2017至2024年复旦大学附属眼耳鼻喉科医院收治的92例声带白斑患者,分析门诊KTP激光治疗的长期疗效与病理分级的关系。末次治疗后平均随访20.53±17.32个月,不典型增生程度越重病灶消退率越低,重度不典型增生和原位癌患者疗效显著差于轻度不典型增生者(p=0.0001)。作者认为KTP激光对轻度病理不典型增生有效,但对重度不典型增生和原位癌应审慎考虑并密切随访。
要点
- 92例声带白斑患者接受门诊KTP激光治疗,平均治疗1.6次,末次治疗后平均随访20.53±17.32个月。
- 病灶消退率:无不典型增生90.1%、轻度不典型增生81.75%、中度不典型增生86.83%、重度不典型增生51.0%、原位癌32.9%。
- 重度不典型增生和原位癌患者疗效显著差于轻度不典型增生者(p=0.0001)。
核心结论
- 门诊KTP激光可有效控制声带白斑疾病进展,疗效与不典型增生程度相关。
- KTP激光对较轻病理不典型增生是有效治疗,但在更严重阶段疗效减弱。
- 对重度不典型增生和原位癌患者应审慎考虑该治疗并密切随访,同时行活检以监测恶变、避免延误治疗。
研究设计与样本
- 回顾性研究,纳入2017至2024年复旦大学附属眼耳鼻喉科医院收治的92例声带白斑患者。
- 末次治疗后平均随访20.53±17.32个月。
- 采用ImageJ分析评估病灶消退以判定疾病控制,采用嗓音障碍指数-30(VHI-30)、GRBAS量表及其他声学参数评估声学结局。
主要发现
- 患者平均接受1.6次治疗。
- 末次治疗后病灶消退率:无不典型增生90.1%,轻度不典型增生81.75%,中度不典型增生86.83%,重度不典型增生51.0%,原位癌32.9%。
- 重度不典型增生和原位癌患者的治疗结局显著差于轻度不典型增生者(p=0.0001)。
关键数值与推荐
- 病灶消退率:无不典型增生90.1%,轻度不典型增生81.75%,中度不典型增生86.83%,重度不典型增生51.0%,原位癌32.9%。
- 重度不典型增生和原位癌与轻度不典型增生比较,治疗结局差异有统计学意义(p=0.0001)。
临床怎么用
- 作者认为门诊KTP激光是较轻病理不典型增生的有效治疗。
- 作者认为对重度不典型增生和原位癌患者应审慎考虑该治疗,并密切随访。
- 作者建议行活检以监测恶变并防止延误治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Vocal fold leukoplakia is commonly managed with outpatient potassium titanyl phosphate (KTP) laser therapy; however, limited data exist on the impact of different pathological grades on long-term efficacy. This study retrospectively analyzed the treatment outcomes, identified prognostic factors, and provided insights to improve disease characterization and clinical management. STUDY DESIGN: Retrospective study (2017-2024). METHODS: Ninety two patients with vocal fold leukoplakia treated in Fudan Eye and ENT hospital (FD-EENT) were included. The mean follow-up period after the last treatment was 20.53 ± 17.32 months. Disease control was assessed by lesion regression using ImageJ analysis. Acoustic outcomes were evaluated using the Voice Handicap Index-30 (VHI-30), GRBAS scale, and other acoustic parameters. RESULTS: Patients underwent a mean of 1.6 treatment sessions. Following the last treatment, the lesion regression rates were 90.1% for no dysplasia, 81.75% for mild dysplasia, and 86.83% for moderate dysplasia, compared to 51.0% for severe dysplasia and 32.9% for carcinoma in situ (CIS). Patients with pathological grades of severe dysplasia and CIS showed significantly poorer treatment outcomes than those with milder dysplasia (***p = 0.0001). CONCLUSION: Outpatient KTP laser effectively controls disease progression in vocal fold leukoplakia, with efficacy linked to the degree of dysplasia. KTP laser is an effective treatment for milder pathological dysplasia, but its efficacy diminishes in more severe stages. The treatment should be carefully considered for patients with severe dysplasia and CIS, with close follow-up, and biopsy should be performed to monitor malignant transformation and prevent delayed treatment.
引用
- Li D, Lu Z, Chen S, et al. Pathological Grading Determines the Clinical Efficacy of Outpatient KTP Laser Treatment for Vocal Fold Leukoplakia. Laryngoscope. 2025. PMID: 40755430. doi:10.1002/lary.32479
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。